Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. Oktober 2025 05:34 ET | Quelle: Research and Markets

Tumor Infiltrating Lymphocytes Therapy Market Research Report 2025-2030: Market Driven by Active R&D from Iovance Biotherapeutics, Juncell Therapeutics, Biosyngen, and Instil Bio

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Global Tumor Infiltrating Lymphocytes Therapy Market Opportunity, Proprietary Technologies Platforms & Clinical Trials Insight 2030" report has...
01. April 2025 14:44 ET | Quelle: Research and Markets

Tumor-infiltrating Lymphocyte (TIL) Therapies Global Market Report 2025: 75+ Therapies are Under Development and 100+ Clinical Trials are Underway Globally

Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions" report has been...
25. März 2025 06:46 ET | Quelle: Research and Markets

T-Cell Therapy Market Research 2025: Over 10 Approved Therapies and More than 1,200 Preclinical / Clinical Therapy Candidates - Global Industry Trends and Forecasts to 2035

Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The "T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of...
08. Juli 2024 20:00 ET | Quelle: Io Therapeutics, Inc.

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound

Io Therapeutics, Inc presented studies in multiple cancers with its novel drug that inhibits tumor growth by promoting tumor infiltrating T-lymphocytes
14. Juni 2024 06:23 ET | Quelle: Research and Markets

CAR-T Therapy Pipeline Landscape Report, 2024 - Features Insights on Emerging Drugs CT053, Descartes-08, ALLO-501A, CTX110, and IMPT 314

Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "CAR-T Therapy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This report provides in-depth insights into the...
23. Januar 2024 09:43 ET | Quelle: Research and Markets

Tumor Infiltrating Lymphocytes Industry Projected to Reach $18.32 Billion by 2028 - Emerging Technologies, such as cytoDRIVE, and Strategic Alliances Propelling the Global Market Forward

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Growth Driven by...
22. Oktober 2020 05:33 ET | Quelle: KuicK Research

Global Tumor Infiltrating Lymphocytes TIL Immunotherapy Markers Market Size Research Companies Clinical Trials Outlook Report 2025

DELHI, India, Oct. 22, 2020 (GLOBE NEWSWIRE) -- "Global Tumor Infiltrating Lymphocytes Immunotherapy Market Opportunity & Clinical Trials Insight 2025" Report Highlights: Tumor Infiltrating...